Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts

REFERENCES

• Anaissie E., Bodey G.P. Nosocomial fungal infections. Old problems and new challenges. Infectious Disease Clinics of North America 1989; 3: 867–882
   PubMedGoogle Scholar
• Bennett J.E., Dismukes W.E., Duma R.J., Medoff G., Sande M.A., Gallis H., Leonard J., Fields B.T., Bradshaw M., Haywood H., McGee Z.A., Cate T.R., Cobbs C.G., Warner J.F., Alling D.W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 1979; 301: 126–126
   PubMed Web of Science ®Google Scholar
• Bullock W.E., Wright S.D. Role of the adherence-promoting receptors CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum, by human macrophages. Journal of Experimental Medicine 1987; 165: 195–210
   PubMed Web of Science ®Google Scholar
• Burch P.A., Karp J.E., Merz W.G., Kuhlman J.E., Fishman E.K. Favorable outcome of invasive aspergillosis in patients with acute leukemia. Journal of Clinical Oncology 1987; 5: 1985–1993
   PubMed Web of Science ®Google Scholar
• Deepe G.S., Brunner G.D. Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas. Infection and Immunity 1990; 58: 1538–1544
   PubMed Web of Science ®Google Scholar
• Deepe G.S., Smith J.G., Sonnenfeld G., Denman D., Bullock W.E. Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infection and Immunity 1986; 54: 714–722
   PubMed Web of Science ®Google Scholar
• Deepe G.S., Taylor C.L., Harris J.E., Bullock W.E. Modulation of cellular immune responses in mice and disseminated histoplasmosis by recombinant interleukin-2. Infection and Immunity 1986; 53: 6–12
   PubMed Web of Science ®Google Scholar
• Denning D.W., Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Reviews of Infectious Diseases 1990; 12: 1147–1201
   PubMedGoogle Scholar
• Dismukes W.E. Combination therapy with amphotericin B and flucytosine for selected systemic mycoses. Diagnosis and Therapy of Systemic Fungal Infections, K. Holmberg, R.D. Meyer. Raven Press Ltd., New York 1989; 121–131, In
   Google Scholar
• Eissenberg L.G., Goldman W.E. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infection and Immunity 1987; 55: 29–34
   PubMed Web of Science ®Google Scholar
• Fleischman N.J., Wu-Hsieh B., Howard D.H. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ. Journal of Infectious Diseases 1990; 161: 143–145
   PubMed Web of Science ®Google Scholar
• Gomez A.M., Bullock W.E., Taylor C.L., Deepe G.S. Role of L3T4+ T-cells in host defense against Histoplasma capsulatum. Infection and Immunity 1988; 56: 1685–1691
   PubMed Web of Science ®Google Scholar
• Goodwin R.A., Des Prez R.M. Pathogenesis and clinical spectrum of histoplasmosis. Southern Medical Journal 1973; 66: 13–25
   PubMed Web of Science ®Google Scholar
• Goodwin R.A., Shapiro J.L., Thurman G.H., Thurman S.S., Des Prez R.M. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine 1980; 59: 1–33
   PubMed Web of Science ®Google Scholar
• Graybill J.R., Palou E., Ahrens J. Treatment of murine histoplasmosis with UK49,858 (fluconazole). American Review of Respiratory Disease 1986; 134: 768–770
   PubMed Web of Science ®Google Scholar
• Graybill J.R., Williams D.M., Van Cutsem E., Drutz D.J. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Reviews of Infectious Diseases 1980; 2: 551–558
   PubMedGoogle Scholar
• Hughes C.E., Peterson L.R., Beggs W.H., Gerding D.N. Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits. Journal of Antimicrobial Chemotherapy 1986; 18: 65–72
   PubMed Web of Science ®Google Scholar
• Johnson P.C., Khardori N., Najjar A.F., Butt F., Mansell P.W.A., Sarosi G.A. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. American Journal of Medicine 1988; 85: 152–158
   PubMed Web of Science ®Google Scholar
• Kobayashi G.S., Travis S.J., Medoff G. Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice. Antimicrobial Agents and Chemotherapy 1987; 31: 2005–2006
   PubMed Web of Science ®Google Scholar
• Larsen R.A., Leal M.A.E., Chan L.S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Annals of Internal Medicine 1990; 113: 183–187
   PubMed Web of Science ®Google Scholar
• Lee J.W., Kelly P., Lecciones J., Coleman D., Gordee R., Pizzo P.A., Walsh T.J. cylofungin (LY121019) shows non-linear plasma pharmacokinetics and tissue penetration in rabbits. Antimicrobial Agents and Chemotherapy 1990; 34: 2240–2245
   PubMed Web of Science ®Google Scholar
• Lee J.W., Lin C., Loebenberg D., Rubin M., Pizzo P.A., Walsh T.J. Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits. Antimicrobial Agents and Chemotherapy 1989; 33: 1932–1935
   PubMed Web of Science ®Google Scholar
• McKinsey D.S., Gupta M.R., Riddler S.A., Driks M.R., Smith D.L., Kurtin P.J. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 1989; 111: 655–659
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Souza L.M., Alton N.K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
   PubMed Web of Science ®Google Scholar
• Newman S.L., Bucher C., Rhodes J., Bullock W.E. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Journal of Clinical Investigation 1990; 85: 223–230
   PubMed Web of Science ®Google Scholar
• Nickerson D.A., Havens R.A., Bullock W.E. Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations. Cellular Immunology 1981; 60: 287–297
   PubMed Web of Science ®Google Scholar
• Patino M.M., Williams D., Ahrens J., Graybill J.R. Experimental histoplasmosis in the beige mouse. Journal of Leukocyte Biology 1987; 41: 228–235
   PubMed Web of Science ®Google Scholar
• Polak A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy 1987; 33: 381–395
   PubMed Web of Science ®Google Scholar
• Polak A., Scholer H.J., Wall M. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy 1982; 28: 461–479
   PubMed Web of Science ®Google Scholar
• Savani D.V., Perfect J.R., Cobo L.M., Durack D.T. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrobial Agents and Chemotherapy 1987; 31: 6–10
   PubMed Web of Science ®Google Scholar
• Schaffner A., Frick P.G. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. Journal of Infectious Diseases 1985; 151: 902–910
   PubMed Web of Science ®Google Scholar
• Smith J.G., Magee M., Williams D.M., Graybill J.R. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. Journal of Infectious Diseases 1990; 162: 1349–1353
   PubMed Web of Science ®Google Scholar
• Suchyta M.R., Smith J.G., Graybill J.R. The role of natural killer cells in histoplasmosis. American Review of Respiratory Disease 1988; 138: 578–582
   PubMed Web of Science ®Google Scholar
• Taylor R.L., Williams D.M., Graven P.C., Graybill J.R., Drutz D.J., Magee W.E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. American Review of Respiratory Disease 1982; 125: 610–611
   PubMed Web of Science ®Google Scholar
• Thaler M., Bacher J., O'Leary T., Pizzo P.A. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. Journal of Infectious Diseases 1988; 158: 80–88
   PubMed Web of Science ®Google Scholar
• Van Cutsem J. Antifungal activity of enilconazole on experimental aspergillosis in chickens. Avian Diseases 1983; 27: 36–42
   PubMed Web of Science ®Google Scholar
• Van Cutsem J. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals. Mycoses 1989; 32(S1)14–34
   PubMed Web of Science ®Google Scholar
• Van Cutsem J., Janssen P.A.J. In vitro and in vivo models to study the activity of antifungals against Aspergillus. Aspergillus and Aspergillosis, H. Vanden Bossche, D.W.R. Mackenzie, G. Cauwenbergh. Plenum Publishing Corporation, New York 1988; 215–227, In
   Google Scholar
• Van Cutsem J., Van Gerven F., Janssen P.A.J. Oral and parenteral therapy with saperconazole of invasive aspergillosis in normal and immunocompromised animals. Antimicrobial Agents and Chemotherapy 1989; 33: 2063–2068
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Aoki S., Mechinaud F., Bacher J., Lee J., Rubin M., Pizzo P.A. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. Journal of Infectious Diseases 1990; 161: 755–760
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Bacher J., Pizzo P.A. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Laboratory Animal Science 1988; 38: 467–471
   PubMedGoogle Scholar
• Walsh T.J., Lee J., Aoki S., Mechinaud F., Bacher J., Lecciones J., Thomas V., Rubin M., Pizzo P.A. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Reviews of Infectious Diseases 1990; 12(Suppl. 3)S307–S317
   PubMedGoogle Scholar
• Walsh T.J., Lee J.W., Kelly P., Bacher J., Lecciones J., Thomas V., Coleman D., Gordee R., Pizzo P.A. Antifungal effects of linear and non-linear pharmacokinetics of cilofungin (LY-121019) — a 1,3-β-glucan synthase inhibitor — by intermittent and continuous infusion in experimental disseminated candidiasis. Antimicrobial Agents and Chemotherapy 1991, in press
   Web of Science ®Google Scholar
• Walsh T.J., Lee J.W., Lecciones J., Kelly P., Peter J., Thomas V., Bacher J., Pizzo P.A. Sch 39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits. Antimicrobial Agents and Chemotherapy 1990; 34: 1560–1564
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Pizzo P.A. Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annual Review of Microbiology 1988; 42: 517–545
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Pizzo P.A. Treatment of systemic fungal infections: recent progress and current problems. European Journal of Clinical Microbiology and Infectious Diseases 1988; 7: 460–475
   PubMed Web of Science ®Google Scholar
• Watson S.R., Schmitt S.K., Hendricks D.E., Bullock W.E. Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. Journal of Immunology 1985; 135: 3487–3493
   PubMed Web of Science ®Google Scholar
• Wheat L.J. Systemic fungal infections: diagnosis and treatment. I. Histoplasmosis. Infectious Disease Clinics of North America 1988; 2: 841–859
   PubMedGoogle Scholar
• Wheat L.J., Connolly-Springfield P.A., Baker R.L., Curfman M.F., Eads M.E., Israel K.S., Norris S.A., Webb D.H., Zeckel M.L. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990; 69: 361–374
   PubMed Web of Science ®Google Scholar
• Williams D.M., Graybill J.R., Drutz D.J. Histoplasma capsulatum infection in nude mice. Infection and Immunity 1978; 21: 973–977
   PubMed Web of Science ®Google Scholar
• Williams D.M., Graybill J.R., Drutz D.J., Levine H.B. Suppression of cryptococcosis and histoplasmosis by ketoconazole in athymic nude mice. Journal of Infectious Diseases 1980; 141: 76–80
   PubMed Web of Science ®Google Scholar
• Wolf J.E., Abegg A.L., Travis S.J., Kobayashi G.S., Little J.R. Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infection and Immunity 1989; 57: 513–519
   PubMed Web of Science ®Google Scholar
• Wu-Hsieh B., Howard D.H. Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages. Journal of Immunology 1984; 132: 2593–2597
   PubMed Web of Science ®Google Scholar
• Wu-Hsieh B.A., Howard D.H. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infection and Immunity 1987; 55: 1014–1016
   PubMed Web of Science ®Google Scholar
• Wu-Hsieh B., Zlotnik A., Howard D.H. T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum. Infection and Immunity 1984; 43: 380–385
   PubMed Web of Science ®Google Scholar